Literature DB >> 29957262

Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries (MINOCA).

Giuseppe Ciliberti1, Stefano Coiro2, Isabella Tritto2, Martina Benedetti2, Federico Guerra3, Maurizio Del Pinto4, Gherardo Finocchiaro5, Claudio Cavallini4, Alessandro Capucci3, Juan Carlos Kaski6, Giuseppe Ambrosio2.   

Abstract

OBJECTIVE: To assess the characteristics and prognosis of patients with myocardial infarction and non-obstructed coronary arteries (MINOCA).
METHODS: MINOCA was defined as acute myocardial infarction (AMI) with angiographic coronary stenosis <50%.Cardiomyopathies and myocarditis were - a priori - excluded from the study. Stenoses <30% were considered normal coronary arteries (NCA); stenoses ≥30% but <50% were considered mild coronary artery disease (MCAD). Patients were subdivided in 3 groups: I) NCA (0 vessels; stenosis <30%); II) 1-2 vessels showing MCAD and III) MCAD in 3 vessels or the left main stem (LMS).
RESULTS: From January 2006 to December 2014, 7935 consecutive AMI patients were entered into our institutional database;150 (2%) were diagnosed as having MINOCA. At a median follow-up of 7.1 years the composite end-point (cardiovascular death, AMI or acute coronary syndrome, heart failure, stroke) occurred in 23 patients (17.4%). Survival analysis showed no differences between NCA versus MCAD (p = 0.781). When assessed by distribution of CAD, group III had a lower event-free survival compared to group I and group II, respectively 54 ± 14%, 83 ± 4% and 90 ± 5% (p = 0.001). In a multivariate model, only 3 vessel disease or LMS involvement (HR = 23.5, 95% CI 2.59-173.49, P = 0.001) and high C-reactive protein at hospital admission (HR = 1.47, 95% CI 1.06-2.07, P = 0.005) were significant predictors of the study composite endpoint.
CONCLUSIONS: In patients with MINOCA, the presence of NCA or 1-2 vessel MCAD was associated with better long-term clinical outcomes compared with patients with MCAD affecting 3 vessels or the LMS. Increased CRP concentrations on hospital admission were also a marker of worse clinical outcome during follow-up.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; Acute myocardial infarction; C-reactive protein; MINOCA; Prognosis

Mesh:

Substances:

Year:  2018        PMID: 29957262     DOI: 10.1016/j.ijcard.2018.03.092

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Clinical Characteristics Predicting Worse Long-Term Outcomes in Patients with Myocardial Infarction and Non-Obstructive Coronary Arteries (MINOCA).

Authors:  Piotr Szolc; Łukasz Niewiara; Paweł Kleczyński; Krzysztof Bryniarski; Elżbieta Ostrowska-Kaim; Kornelia Szkodoń; Piotr Brzychczy; Krzysztof Żmudka; Jacek Legutko; Bartłomiej Guzik
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-26

2.  Clinical presentation and 3-year outcomes of patients with acute coronary syndromes and non-obstructive coronary arteries on angiography.

Authors:  Lukasz Zandecki; Agnieszka Janion-Sadowska; Jacek Kurzawski; Lukasz Piatek; Michal Zabojszcz; Krzysztof Plens; Zbigniew Siudak; Marcin Sadowski
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

Review 3.  Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): a position paper from the Dutch ACS working group.

Authors:  T F S Pustjens; Y Appelman; P Damman; J M Ten Berg; J W Jukema; R J de Winter; W R P Agema; M L J van der Wielen; F Arslan; S Rasoul; A W J van 't Hof
Journal:  Neth Heart J       Date:  2020-03       Impact factor: 2.380

4.  Risk of bleeding with ticagrelor in elderly patients over 75 years old: A systematic review and meta-analysis.

Authors:  Shalan Alaamri; Sultan Al Dalbhi
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817

5.  Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries.

Authors:  Kai M Eggers; Tomasz Baron; Marcus Hjort; Anna M Nordenskjöld; Per Tornvall; Bertil Lindahl
Journal:  Clin Cardiol       Date:  2021-05-25       Impact factor: 2.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.